Trial · NCT07882732
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 23
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of hospitalization | Day 0 through Day +14 | Number and percentage of participants hospitalized. |
| Primary | Time to hospital admission | Day 0 through Day +14 | Number of days between infusion and hospital admission, reported as median (IQR) and range. |
| Primary | Reason for hospitalization | Day 0 through Day +14 | Number and percent of participants for each hospitalization reason. |
| Primary | Hospital length of stay | Day 0 through Day +14 | Number of days in hospital (midnight to midnight), reported as median (IQR) and range. |
| Primary | Incidence of ICU admission | Day 0 through Day +14 | Number and percentage of participants admitted to an intensive care unit |
| Primary | Time to ICU admission | Day 0 through Day +14 | Number of days between infusion and ICU admission, reported as median (IQR) and range. |
| Primary | Reason for ICU admission | Day 0 through Day +14 | Number and percent of participants for each icu admission reason. |
| Primary | ICU length of stay | Day 0 through Day +14 | Number of days in ICU (midnight to midnight), reported as median (IQR) and range. |
| Primary | Incidence of emergency department visits | Day 0 through Day +14 | Number and percentage of participants with at least one emergency department visit |
| Primary | Time to first emergency department visit | Day 0 through Day +14 | Number of days between infusion and first visit, reported as median (IQR) and range. |
| Primary | Reason for emergency department visit | Day 0 through Day +14 | Number and percent of emergency department visits for each reason. |
| Primary | Mortality | Day 0 through Day 14 | Number and percentage of participants who died. |
| Primary | Incidence of Cytokine Release Syndrome (CRS) | Day 0 through Day +14 | Number and percentage of participants with CRS |
| Primary | Grade of Cytokine Release Syndrome (CRS) | Day 0 through Day +14 | Distribution of maximum CRS grade (Grade 0-4) per ASTCT consensus criteria (Lee 2019). |
| Primary | Time to onset of Cytokine Release Syndrome (CRS) | Day 0 through Day +14 | Days from infusion to CRS onset, reported as median (IQR) and range. |
| Primary | Incidence of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) | Day 0 through Day +14 | Number and percentage of participants with ICANS |
| Primary | Grade of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) | Day 0 through Day +14 | Distribution of maximum ICANS grade (Grade 0-4) per ASTCT criteria (Lee 2019). |
| Primary | Time to onset of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) | Day 0 through Day +14 | Days from infusion to ICANS onset, reported as median (IQR) and range. |
| Primary | Prophylaxis for CAR T-Related Toxicities | Day -3 through Day +14 | Number and percentage of participants receiving prophylaxis (corticosteroids, anakinra, tocilizumab, other) for CAR T-related side effects, overall and by type. |
| Primary | Treatment of CAR T-Related Toxicities | Day 0 through Day +14 | Number and percentage of participants receiving treatment for CAR T-related side effects (antipyretics, corticosteroids, anakinra, tocilizumab, transfusion, antibiotics, antiemetics, other), overall and by type. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07882732/registered